Cancers, Vol. 12, Pages 2899: Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer
Cancers, Vol. 12, Pages 2899: Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer
Cancers doi: 10.3390/cancers12102899
Authors:
Sharad Purohit
Wenbo Zhi
Daron G. Ferris
Manual Alverez
Lynn Kim Hoang Tran
Paul Minh Huy Tran
Boying Dun
Diane Hopkins
Bruno dos Santos
Sharad Ghamande
Jin-Xiong She
Molecular biomarkers that can predict survival and therapeutic outcome are still lacking for cervical cancer. Here we measured a panel of 19 serum proteins in sera from 565 patients with stage II or III cervical cancer and identified 10 proteins that have an impact on disease specific survival (DSS) (Hazzard’s ratio; HR = 1.51–2.1). Surprisingly, all ten proteins are implicated in senescence-associated secreted phenotype (SASP), a hallmark of cellular senescence. Machine learning using Ridge regression of these SASP proteins can robustly stratify patients with high SASP, which is associated with poor survival, and patients with low SASP associated with good survival (HR = 3.09–4.52). Furthermore, brachytherapy, an effective therapy for cervical cancer, greatly improves survival in SASP-high patients (HR = 3.3, p < 5 × 10−5) but has little impact on survival of SASP-low patients (HR = 1.5, p = 0.31). These results demonstrate that cellular senescence is a major determining factor for survival and therapeutic response in cervica...
Source: Cancers - Category: Cancer & Oncology Authors: Sharad Purohit Wenbo Zhi Daron G. Ferris Manual Alverez Lynn Kim Hoang Tran Paul Minh Huy Tran Boying Dun Diane Hopkins Bruno dos Santos Sharad Ghamande Jin-Xiong She Tags: Article Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Learning | Universities & Medical Training